Krais, J. J., Wang, Y., Bernhardy, A. J., Clausen, E., Miller, J. A., Cai, K. Q., . . . Johnson, N. (2020). RNF168-mediated ubiquitin signaling inhibits the viability of BRCA1 null cancers. Cancer Res.
Citación estilo ChicagoKrais, John J., Yifan Wang, Andrea J. Bernhardy, Emma Clausen, Jessica A. Miller, Kathy Q. Cai, Clare L. Scott, y Neil Johnson. "RNF168-mediated Ubiquitin Signaling Inhibits the Viability of BRCA1 Null Cancers." Cancer Res 2020.
Cita MLAKrais, John J., et al. "RNF168-mediated Ubiquitin Signaling Inhibits the Viability of BRCA1 Null Cancers." Cancer Res 2020.
Precaución: Estas citas no son 100% exactas.